Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1999-01-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.96.1.179PMID 9874792PMCID PMC15113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

  1998cited by this paper
• The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity

  1998cited by this paper
• Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

  1998cited by this paper
• Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.

  1998cited by this paper
• Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.

  1998cited by this paper
• Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

  1998cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

  1997cited by this paper
• Caenorhabditis elegans rab-3 Mutant Synapses Exhibit Impaired Function and Are Partially Depleted of Vesicles

  1997cited by this paper
• Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.

  1997cited by this paper
• Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel

  1997cited by this paper
• Intranuclear Neuronal Inclusions : Minireview A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases ?

  1997cited by this paper
• Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• The complex pathology of trinucleotide repeats.

  1997cited by this paper
• Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion

  1997cited by this paper
• Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?

  1997cited by this paper
• Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT

  1996cited by this paper
• Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats

  1996cited by this paper
• Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2

  1996cited by this paper
• Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo

  1996cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Normal and Expanded Huntington’s Disease Gene Alleles Produce Distinguishable Proteins Due to Translation Across the CAG Repeat

  1995cited by this paper
• Huntington's disease: CAG genetics expands neurobiology

  1995cited by this paper
• Synaptic code for sensory modalities revealed by C. elegans GLR-1 glutamate receptor

  1995cited by this paper
• Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

  1995cited by this paper
• Divergent seven transmembrane receptors are candidate chemosensory receptors in C. elegans.

  1995cited by this paper
• Mutations affecting the chemosensory neurons of Caenorhabditis elegans.

  1995cited by this paper
• Chapter 19 DNA Transformation

  1995cited by this paper
• In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes

  1995cited by this paper
• SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

  1995cited by this paper
• DNA transformation.

  1995cited by this paper
• Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA)

  1994cited by this paper
• Programmed cell death in Caenorhabditis elegans.

  1994cited by this paper
• CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

  1994cited by this paper
• A dual mechanosensory and chemosensory neuron in Caenorhabditis elegans.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1

  1993cited by this paper
• Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues

  1993cited by this paper
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

  1991cited by this paper
• Analysis of dominant-negative mutations of the Caenorhabditis elegans let-60 ras gene.

  1991cited by this paper
• A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans.

  1990cited by this paper
• Chemosensory cell function in the behavior and development of Caenorhabditis elegans.

  1990cited by this paper
• Huntington's disease. Pathogenesis and management.

  1986cited by this paper
• Mutant sensory cilia in the nematode Caenorhabditis elegans.

  1986cited by this paper
• Axonal guidance mutants of Caenorhabditis elegans identified by filling sensory neurons with fluorescein dyes.

  1985cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper

• Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in Caenorhabditis elegans

  2025cites this paper
• Unconventional Non-rodent Models in Neurological Research: Exploring New Paths to Translational Insights

  2025cites this paper
• APOE4-induced patterned behavioral decline and neurodegeneration requires endogenous tau in a C. elegans model of Alzheimer’s disease

  2025cites this paper
• Evaluating polyglutamine protein aggregation and toxicity in transgenic Caenorhabditis elegans models of Huntington's disease.

  2025cites this paper
• Downregulation of Pten Improves Huntington’s Disease Phenotype by Reducing Htt Aggregates and Cell Death

  2025cites this paper
• Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review

  2025cites this paper
• Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disorders.

  2025cites this paper
• Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models

  2025cites this paper
• Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities

  2025cites this paper
• A Comprehensive Review on Redundancy usage of Animal models in Novel Drug testing

  2024cites this paper
• C. elegans: a prominent platform for modeling and drug screening in neurological disorders

  2024cites this paper
• Protective role of Pten downregulation in Huntington’s Disease models

  2024cites this paper
• Advantages and differences among various animal models of Huntington’s disease

  2024cites this paper
• Olfactory dysfunction as an early pathogenic indicator in C. elegans models of Alzheimer's and polyglutamine diseases

  2024cites this paper
• Quinic acid protects against the development of Huntington’s disease in Caenorhabditis elegans model

  2024cites this paper
• Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases.

  2023cites this paper
• Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans

  2023influential citation
• Modeling Huntington's disease: An insight on in-vitro and in-vivo models.

  2023cites this paper
• Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders

  2023cites this paper
• Toxicity of Copper and Zinc alone and in combination in Caenorhabditis elegans model of Huntington's disease and protective effects of rutin.

  2023cites this paper
• Crosstalk between protein misfolding and endoplasmic reticulum stress during ageing and their role in age-related disorders.

  2023cites this paper
• Amphid sensory neurons of Caenorhabditis elegans orchestrate its survival from infection with broad classes of pathogens

  2023cites this paper
• Lipid binding properties of huntingtin as a novel therapeutic target

  2023cites this paper
• Generation of a C. elegans tdp-1 null allele and humanized TARDBP containing human disease-variants.

  2023cites this paper
• Animal models and their substitutes in biomedical research

  2022cites this paper
• The use of CRISPR to generate a whole-gene humanized MAPT and the examination of P301L and G272V clinical variants, along with the creation of deletion null alleles of ptl-1, pgrn-1 and alfa-1 loci

  2022cites this paper
• Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations

  2022influential citation
• On : Alternative To In vivo Experimental Study In Pharmacology "

  2022cites this paper
• C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration

  2022cites this paper
• Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools

  2022cites this paper
• Invited review: Unearthing the mechanisms of age-related neurodegenerative disease using Caenorhabditis elegans.

  2022cites this paper
• A single chemosensory GPCR is required for a concentration-dependent behavioral switching in C. elegans.

  2021cites this paper
• Emergence of Caenorhabditis elegans as a Model Organism for Dissecting the Gut–Brain Axis

  2021cites this paper
• Low-cost optofluidic add-on enables rapid selective plane illumination microscopy of C. elegans with a conventional wide-field microscope

  2021cites this paper
• Arginine as a Disease-Modifying Therapeutic Candidate for the Polyglutamine Diseases by Stabilizing Polyglutamine Protein Conformation and Inhibiting its Aggregation

  2021cites this paper
• Neuroprotective effects of rutin on ASH neurons in Caenorhabditis elegans model of Huntington’s disease

  2021influential citation
• Drug discovery: Insights from the invertebrate Caenorhabditis elegans

  2021cites this paper
• Insect in vitro System for Toxicology Studies — Current and Future Perspectives

  2021cites this paper
• Biophysical phenotyping of C. elegans in a microfluidic chip for high-throughput drug screening

  2021cites this paper
• Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases

  2021cites this paper
• An apparent core/shell architecture of polyQ aggregates in the aging Caenorhabditis elegans neuron

  2021cites this paper
• C. elegans Models to Study the Propagation of Prions and Prion-Like Proteins

  2020cites this paper
• Caenorhabditis elegans as a model system for human diseases.

  2020cites this paper
• C. elegans to model autophagy-related human disorders.

  2020cites this paper
• Modeling neurodegeneration in Caenorhabditis elegans

  2020cites this paper
• Unexpected cell type-dependent effects of autophagy on polyglutamine aggregation revealed by natural genetic variation in C. elegans

  2020cites this paper
• Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases.

  2020cites this paper
• Caenorhabditis elegans as a model organism for protein homeostasis diseases

  2020cites this paper
• Tyrosine phosphorylation regulates hnRNPA2 granule protein partitioning and reduces neurodegeneration

  2020influential citation
• Caenorhabditis elegans-on-a-chip: microfluidic platforms for high-resolution imaging and phenotyping

  2020cites this paper
• Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.

  2020cites this paper
• Rutin protects Huntington's disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: Study in Caenorhabditis elegans model.

  2020cites this paper
• Caenorhabditis elegans as a model system for studying aging-associated neurodegenerative diseases

  2020cites this paper
• Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?

  2020cites this paper
• Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Caenorhabditis elegans Model of Tauopathy

  2019cites this paper
• C. elegans as a Model for Synucleinopathies and Other Neurodegenerative Diseases: Tools and Techniques.

  2019cites this paper
• High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics

  2019cites this paper
• Homeostatic plasticity in neuronal cultures from the YAC128 Huntington disease model mouse

  2019cites this paper
• Applications of the Free-Living Nematode, Caenorhabditis Elegans: A Review

  2019cites this paper
• Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells.

  2019cites this paper
• Modern approaches for modelling dystonia and Huntington's disease in vitro and in vivo

  2019cites this paper
• Quality Control in Huntington’s Disease: a Therapeutic Target

  2019cites this paper
• Natural variants in C. elegans atg-5 3’UTR uncover divergent effects of autophagy on polyglutamine aggregation in different tissues

  2019cites this paper
• Defining the Properties and Toxicity Mechanisms of Non-Canonical Translation Products Associated with ALS and Huntington’s Disease Using C. elegans

  2019influential citation
• Cell-Nonautonomous Regulation of Proteostasis in Aging and Disease.

  2019cites this paper
• PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions

  2019cites this paper
• Automated Operant Assessments of Huntington's Disease Mouse Models.

  2018cites this paper
• Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington’s Disease

  2018cites this paper
• Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases.

  2018cites this paper
• Nonmammalian Models of Huntington's Disease.

  2018cites this paper
• Comparative Analysis of Mutant Huntingtin Binding Partners in Yeast Species

  2018cites this paper
• Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration

  2018cites this paper
• A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation

  2018cites this paper
• Genetic pathways to Neurodegeneration Models and mechanisms of repeat expansion disorders : a worm ’ s eye view

  2018cites this paper
• What Can We Learn About Human Disease from the Nematode C. elegans?

  2018cites this paper
• Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences

  2018cites this paper
• Models and mechanisms of repeat expansion disorders: a worm’s eye view

  2018cites this paper
• Dual role of cdk5 on cognitive deficits and striatal vulnerability in huntington's disease

  2018cites this paper
• Longevity Regulation by Insulin/IGF-1 Signalling

  2017cites this paper
• Protein Homeostasis and Ageing in C. elegans

  2017cites this paper
• Nonmammalian Animal Models of Spinal Muscular Atrophy

  2017cites this paper
• Approaches for Studying Autophagy in Caenorhabditis elegans

  2017cites this paper
• Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model

  2017cites this paper
• A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles

  2017cites this paper
• Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases

  2017cites this paper
• In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model

  2017cites this paper
• Identification and characterization of mediators of toxicity of Aβ oligomers by genome wide screening in Caenorhabditis elegans

  2017cites this paper
• Discovering Capacity in Novel Targets: C. Elegans Toxicological Research

  2017cites this paper
• Huntington's Disease and Other Choreas

  2017cites this paper
• C. elegans screening strategies to identify pro-longevity interventions.

  2016cites this paper
• Endoplasmic reticulum stress: The cause and solution to Huntington's disease?

  2016cites this paper
• In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C. elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects

  2016cites this paper
• Relevance of Small Laboratory Animals as Models in Translational Research: Challenges and Road Ahead.

  2016cites this paper
• Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington's Disease.

  2016cites this paper
• The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease

  2016influential citation
• Cratoxylum formosum Extract Protects against Amyloid-Beta Toxicity in a Caenorhabditis elegans Model of Alzheimerʼs Disease

  2016cites this paper
• Behavioral analysis of the huntingtin‐associated protein 1 ortholog trak‐1 in Caenorhabditis elegans

  2016cites this paper
• Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.

  2016cites this paper
• Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model

  2016cites this paper
• The role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogaster

  2016cites this paper